For the year ending 2025-12-31, HON had $1,920M increase in cash & cash equivalents over the period. $5,422M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income attributable to honeywell | - | 5,705 | 5,658 | 4,966 |
| Net income from continuing operations | 4,468 | - | - | - |
| Depreciation | 546 | 671 | 659 | 657 |
| Amortization | 842 | 663 | 517 | 547 |
| Loss (gain) on sale of non-strategic businesses and assets | -18 | -1 | 5 | 22 |
| Impairment of goodwill | 724 | - | - | - |
| Impairment of assets held for sale | 270 | 219 | - | - |
| Repositioning and other (gains) charges | -167 | 244 | 860 | 1,266 |
| Severance and exit cost payments | 153 | 195 | 294 | 275 |
| Environmental payments | 175 | 224 | 196 | 211 |
| Reimbursement receipts | 105 | 140 | 140 | 140 |
| Insurance receipts for asbestos-related liabilities | 17 | 24 | 39 | 37 |
| Insurance receivables settlements and write-offs | - | - | 26 | 68 |
| Insurance receivables settlements, write-offs, and other | 0 | 9 | - | - |
| Asbestos-related liability payments-Asbestos Related Liabilities | - | - | - | 271 |
| Asbestos-related liability payments | 172 | 233 | 174 | - |
| Net payments for repositioning and other charges | 378 | 479 | 459 | 512 |
| Narco buyout payment | 0 | 0 | 1,325 | - |
| Resideo indemnification and reimbursement agreement termination payment | 1,590 | - | - | - |
| Asbestos liabilities divestiture payment | 1,428 | - | - | - |
| Pension and other postretirement income | -396 | -476 | -406 | -510 |
| Pension and other postretirement benefit payments | 20 | 32 | 38 | 23 |
| Stock compensation expense | 196 | 194 | 202 | 188 |
| Deferred income taxes | 18 | -233 | 153 | -180 |
| Reimbursement receivables charge | - | - | - | 0 |
| Other | -144 | 617 | 837 | 358 |
| Accounts receivable | 825 | 96 | 42 | 739 |
| Inventories | 636 | 304 | 626 | 440 |
| Other current assets | 233 | -371 | -17 | -232 |
| Accounts payable | 724 | 95 | 518 | -155 |
| Accrued liabilities | 1,325 | 171 | 494 | 357 |
| Income taxes | -707 | - | - | - |
| Net cash provided by operating activities from continuing operations | 6,075 | - | - | - |
| Net cash provided by operating activities from discontinued operations | 333 | - | - | - |
| Net cash provided by operating activities | 6,408 | 6,097 | 5,340 | 5,274 |
| Capital expenditures | 986 | 1,164 | 1,039 | 766 |
| Proceeds from disposals of property, plant and equipment | 31 | 0 | 43 | 29 |
| Increase in investments | 1,503 | 1,077 | 560 | 1,211 |
| Decrease in investments | 1,469 | 870 | 971 | 1,255 |
| Receipts from garrett motion inc | - | 0 | 0 | 409 |
| (payments) receipts from settlements of derivative contracts | 399 | -94 | -6 | -369 |
| Cash paid for acquisitions, net of cash acquired | 2,211 | 8,880 | 718 | 178 |
| Proceeds from sales of businesses, net of fees paid | 1,157 | 0 | 4 | 0 |
| Net cash used for investing activities from continuing operations | -2,442 | - | - | - |
| Net cash used for investing activities from discontinued operations | -269 | - | - | - |
| Net cash used for investing activities | -2,711 | -10,157 | -1,293 | -93 |
| Proceeds from issuance of commercial paper and other short-term borrowings | 24,297 | 13,838 | 12,991 | 7,661 |
| Payments of commercial paper and other short-term borrowings | 22,815 | 11,578 | 13,663 | 8,447 |
| Proceeds from issuance of common stock | 237 | 537 | 196 | 320 |
| Proceeds from issuance of long-term debt | 4,035 | 10,408 | 2,986 | 2,953 |
| Payments of long-term debt | 2,909 | 1,812 | 1,731 | 1,850 |
| Repurchases of common stock | 3,804 | 1,655 | 3,715 | 4,200 |
| Cash dividends paid | 2,976 | 2,902 | 2,855 | 2,719 |
| Pre-separation funding | 1,962 | - | - | - |
| Spin-off cash | 449 | - | - | - |
| Other | 469 | 3 | 28 | -48 |
| Net cash (used for) provided by financing activities | -1,953 | 6,839 | -5,763 | -6,330 |
| Effect of foreign exchange rate changes on cash and cash equivalents | 176 | -137 | 14 | -183 |
| Net increase (decrease) in cash and cash equivalents | 1,920 | 2,642 | -1,702 | -1,332 |
| Cash and cash equivalents at beginning of period | 10,567 | 7,925 | 9,627 | 10,959 |
| Cash and cash equivalents at end of period | 12,487 | 10,567 | 7,925 | 9,627 |
HONEYWELL INTERNATIONAL INC (HON)
HONEYWELL INTERNATIONAL INC (HON)